Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 2/20 | 0.71 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.70 |
| ▸ | GLP1R | P43220 | 6/20 | 0.69 |
| ▸ | NPY1R | P25929 | 1/20 | 0.68 |
| ▸ | NPY2R | P49146 | 1/20 | 0.68 |
| ▸ | NPY4R | P50391 | 1/20 | 0.68 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.68 |
| ▸ | CALCR | P30988 | 3/20 | 0.66 |
| ▸ | PTH1R | Q03431 | 4/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30658320 | 0.95 | NPY1R (0.68) | CXCR4KEAP1GLP1RNPY1RNPY2R | |
| SCHEMBL30658403 | 0.95 | CXCR4 (0.71) | CXCR4KEAP1GLP1RNPY1RNPY2R | |
| SCHEMBL29949636 | 0.93 | NPY1R (0.71) | CXCR4KEAP1GLP1RNPY1RNPY2R | |
| SCHEMBL31182694 | 0.93 | CXCR4 (0.71) | CXCR4KEAP1GLP1RNPY1RNPY2R | |
| SCHEMBL31182766 | 0.93 | PTH1R (0.73) | CXCR4KEAP1GLP1RNPY1RNPY2R | |
| SCHEMBL30932069 | 0.93 | GLP1R (0.74) | KEAP1GLP1RNPY1RNPY2RNPY4R | |
| SCHEMBL30658254 | 0.93 | KEAP1 (0.72) | CXCR4KEAP1GLP1RNPY1RNPY2R | |
| SCHEMBL29436020 | 0.93 | GLP1R (0.68) | CXCR4GLP1RNPY1RNPY2RNPY4R | |
| SCHEMBL30658240 | 0.92 | NPY2R (0.74) | CXCR4GLP1RNPY1RNPY2RNPY4R | |
| SCHEMBL30658243 | 0.92 | GLP1R (0.69) | KEAP1GLP1RNPY1RNPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753627-B2 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-09-12 | — | — | US | disclosed |